Rating History for PhaseBio Pharmaceuticals Inc. (PHAS) by TD Cowen
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/24/2022 | Phil Nadeau | Downgrade | Hold (Buy) |
N/A (N/A) |
0.20 (0.07) |
-65% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/24/2022 | Phil Nadeau | Downgrade | Hold (Buy) |
N/A (N/A) |
0.20 (0.07) |
-65% | Details |
![]() |
|||||||